Brain Canada Invests in Expansion of National Neuromuscular Disease Registry to Advance Patient-Centered Research Français
CALGARY, AB, May 27, 2025 /CNW/ - Brain Canada is investing in transformative research platforms across the country to accelerate neuroscience discovery and improve outcomes for people living with brain-related conditions. As part of this national initiative, Dr. Lawrence Korngut at the University of Calgary has been awarded a 2024 Platform Support Grant (PSG) of $553,660 to expand the Canadian Neuromuscular Disease Registry (CNDR) into a multi-modal, open science platform.
"By expanding the CNDR, we're deepening our understanding of the lived experience of people with neuromuscular disorders. This evolution not only supports the development of better treatments but also ensures that patient voices are reflected in the data that drives discovery."
— Dr. Lawrence Korngut, University of Calgary
"This audacious national effort reflects Brain Canada's commitment to a culture of open science grounded in transparency, collaboration, and increased access to shared resources, services, facilities and more."
— Dr. Viviane Poupon, President and CEO of Brain Canada.
The Platform Support Grants program is a cornerstone of Brain Canada's strategy to strengthen the country's neuroscience and mental health research infrastructure. By supporting shared platforms, including databases, biobanks, specialized equipment, and research facilities, the program enables collaboration, accelerates discovery, and expands access to cutting-edge tools to Canadian scientists.
The ambitious task of studying the brain calls for integrated and collaborative research platforms. By funding these platforms, we are building a foundation that Canadian researchers will use to strengthen the future of all neuroscience and mental health research. Brain Canada is committed to fostering a culture of open science through transparency and collaboration.
Brain Canada is contributing over $18 million in this year's PSG program through the Canada Brain Research Fund (CBRF), funded by Health Canada, as well as matching donations from sponsors for a total investment of $36.8 million. By enabling access to cutting-edge tools and specialized skills beyond the reach of individual researchers, the PSG program plays a vital role in strengthening the research landscape.
Over the coming weeks, Brain Canada will unveil the full list of 14 research platforms selected to receive PSG funding. The total investment of $36.8 million represents a major step forward in Canada's ability to support cutting-edge brain research and improve outcomes for people living with brain-disorders.
The Canadian Neuromuscular Disease Registry (CNDR) supports research and tracks the effectiveness of treatments for neuromuscular disorders (NMDs), which are rare and complex conditions that affect nerves and muscles. By collecting data from over 40 clinics with more that 5,800 patients across Canada and collaborating with over 130 researchers, the CNDR has become an extensive network for standardized data collection and a valuable resource for advancing research in NMDs. Integrating patient-reported outcome measures into its various registries, including a new one for fascioscapulohumeral muscular dystrophy (FSHD), to capture severity and quality of life more frequently, will improve our understanding of the lived experience of people with NMDs and add depth to CNDR data across all diseases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
3 hours ago
- Cision Canada
Fraser Institute News Release: 84% of Swiss hospitals and 60% of hospitalizations are in private facilities, and they face much lower wait times
VANCOUVER, BC, June 12, 2025 /CNW/ - If Canada reformed to emulate Switzerland's approach to universal health care, including its much greater use of private sector involvement, the country would deliver far better results to patients and reduce wait times, finds a new study published today by the Fraser Institute, an independent, non-partisan Canadian policy think-tank. "The bane of Canadian health care is lack of access to timely care, so it's critical to look to countries like Switzerland with more successful universal health care," said Yanick Labrie, senior fellow at the Fraser Institute and author of Integrating Private Health Care Into Canada's Public System: What We Can Learn from Switzerland. The study highlights how Switzerland successfully integrates the private sector into their universal health-care system, which consistently outperforms Canada on most health-care metrics, including wait times. For example, in 2022, the percentage of patients who waited less than two months for a specialist appointment was 85.3 per cent in Switzerland compared to just 48.3 per cent in Canada. In Switzerland, 84.2 per cent of all hospitals are private (either for-profit or not-for-profit) institutions, and the country's private hospitals provide 60.2 per cent of all hospitalizations, 60.9 per cent of all births, and 67.1 per cent of all operating rooms. Crucially, Swiss patients can obtain treatment at the hospital of their choice, whether located inside or outside their geographic location, and hospitals cannot discriminate against patients, based on the care required. "Switzerland shows that a universal health-care system can reconcile efficiency and equity–all while being more accessible and responsive to patients' needs and preferences," Labrie said. "Based on the success of the Swiss model, provinces can make these reforms now and help improve Canadian health care." The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit SOURCE The Fraser Institute
Vancouver Sun
8 hours ago
- Vancouver Sun
Canadians still waiting longer for surgeries than before COVID
The massive surgical backlogs left after rolling pandemic lockdowns are clearing but Canadians are still waiting longer than they were pre-COVID for new hips and knees, cancer surgeries and other 'priority' procedures, new data show. Even though 26 per cent more hip and knee replacements were done in 2024 than 2019, it still wasn't enough to meet the need: just 68 per cent of Canadians received a hip replacement within the 26-week benchmark last year, compared to 75 per cent in 2019. For those needing a knee replacement, 61 per cent got a slot in the operating room within the 182-day threshold, compared with 70 per cent in 2019, even though 21 per cent more knee replacements were performed in 2024 than in 2019. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Median wait times for breast, bladder, colorectal, lung and prostate cancer surgery also rose, with prostate cancer seeing the biggest bump in wait times, an extra nine days over 2019. Wait times for scans to diagnose diseases and injuries also increased, 'with MRI scans requiring an additional 15 days and CTS scans three more days compared with 2019,' the Canadian Institute for Health Information (CIHI) reported in a background release. Canadians waited a median 57 days for an MRI scan in 2024. One in 10 waited 198 days. The longer people wait, the more they deteriorate. Delays getting to an operating room 'can lead to disease progression, increased symptoms of anxiety and depression, risk of mental health flareups and worsening of surgical and nonsurgical patient outcomes,' Canadian researchers have warned. Hospitals across the country pushed back non-urgent surgeries during the early waves of COVID to free up beds. Almost 600,000 fewer operations were performed in the first 22 months of the pandemic alone compared to 2019, CIHI reported. The backlog has meant that by the time people see a surgeon, their problem is more complex than it would have been in the past, Dr. James Howard, chief of orthopedic surgery at University Hospital – London Health Sciences Centre said in the news release. Canada's aging baby boomer generation, with arthritis and other joint conditions, is also putting pressure on the system. 'So even with surgeons collectively working as much as they can and completing more surgeries than we have in the past, we are not seeing wait times come down due to the complexity and volume of patients presenting to orthopedic surgeons,' Howard said. While case numbers are bouncing back — five per cent more surgeries of all types were performed in 2023 than in 2019 — the volumes still haven't kept up with population growth (seven per cent over the same period) or the 10 per cent rise in demand for surgery among those 65 and older, CIHI reported. 'Although an increase in the volume of procedures performed across Canada means that the surgical backlog from the height of the pandemic period has effectively been cleared, ripple effects in the health systems — due in part to the pandemic — persist that impact wait times in Canada,' CIHI's Cheryl Chui, director of health system analytics, said in a statement. Factors driving those longer wait times include a shortage of specialists and nurses, limited operating room time, space and staff, and emergency cases that take priority over scheduled ones. Ontario and other provinces are trying to push through more surgeries and procedures, partly by doing more on an outpatient basis, meaning no overnight hospital stay. Ontario has also announced plans to expand the number of private clinics providing publicly covered hip and knee replacements. Other provinces have done the same, though 'the impact on surgical volumes and wait times is still being assessed,' CIHI said. According to the agency's latest waitlist snapshot, while the number of hip replacements increased from 22,000 in 2019, to 28,000 in 2024, and the number of knee replacements from 35,000 to 42,000 over the same period, a smaller proportion of people received joint replacement surgery within the recommended six months. Nationally, in 2024, only 68 per cent of people needing a new hip were treated within the 26-week benchmark, compared to 75 per cent in 2019. Ontario fared better than all other provinces: 82 per cent of hip replacement patients were treated within that timeframe. Newfoundland and Labrador (41 per cent) and Prince Edward Island (45 per cent) performed the worst. British Columbia (63 per cent), Saskatchewan (50 per cent), Manitoba (54 per cent) and Quebec (49 per cent) also scored below the proportion nationally. In Alberta, 73 per cent of hip replacements were performed within the benchmark in 2024. Ripple effects in the health systems — due in part to the pandemic — persist that impact wait times in Canada Overall, patients waited a median 125 days for hip surgery in 2024 (half waited less, half waited more). One in 10 waited 340 days. For knee replacements, 79 per cent of patients in Ontario received surgery within the 26-week benchmark in 2024, compared to 38 per cent in Quebec, 47 per cent in Saskatchewan, 55 per cent in B.C. and 62 per cent in Alberta. While efforts are being made to better manage and monitor surgical waitlists, researchers have warned that people with severe pain or worsening symptoms aren't being prioritized. Wait times for cataract surgery were close to pre-pandemic levels — 69 per cent of people were treated within a 16-week benchmark in 2024 versus 70 per cent in 2019. The percentage of people who received radiation therapy within 28 days and surgery to repair a fractured hip within 48 hours dropped slightly, by three percentage points from 2019 to 2024, falling to 94 per cent and 83 per cent, respectively. The volume of prostate cancer surgeries performed dropped by three per cent, from 3,500 in 2019, to 3,400 in 2024. And men waited longer for the procedure — from a median 41 days in 2019, to 50 days in 2024. Slower-growing cancers like prostate cancer tend to have the longest surgical wait times, CIHI reported. Median wait times for breast cancer surgery increased from 18 days in 2019 to 23 days in 2024, and wait times for bladder cancer increased from 24 days to 28 days. National Post Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
Vancouver Sun
13 hours ago
- Vancouver Sun
Opinion: Exercise improves cancer survival — and a Canadian study leads the way
Last week, history was made in the world of cancer research — not with a new drug, but with something far more accessible and powerful: exercise. A landmark study published in The New England Journal of Medicine has confirmed, for the first time in a randomized controlled trial, that a structured exercise program can significantly improve survival for people treated for early-stage colon cancer. The Challenge trial showed that a three-year structured exercise program initiated after chemotherapy reduced the risk of cancer recurrence or death by 28 per cent, and improved overall survival by 37 per cent. Compared to health education alone, this was a 7.1 per cent improvement in the likelihood of being alive at the eight-year mark. Let that sink in: Brisk walking a few times a week can improve survival as much — or more — than many modern cancer drugs, with none of the side effects and at a fraction of the cost. A daily roundup of Opinion pieces from the Sun and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Informed Opinion will soon be in your inbox. Please try again Interested in more newsletters? Browse here. For years, observational studies hinted that physically active cancer survivors tended to live longer and feel better. But these studies were limited by their design — confounded by the fact that healthier people might be more likely to exercise. Now, the Challenge trial provides the gold-standard evidence we've been waiting for — led by Drs. Christopher Booth and Kerry Courneya through the Canadian Cancer Trials Group, this 'first-in-class' trial enrolled 889 patients in Canada, Australia, and the UK and confirmed that supervised exercise with behaviour change support improves both disease-free and overall survival, while enhancing physical functioning and quality of life. This has profound implications for cancer care — and for our health system. First, it's time to redefine 'treatment.' Cancer care has long focused on surgery, chemotherapy, and radiation. But what happens after treatment is often an afterthought. Survivors may be left with side effects, fatigue, and fear of recurrence, and limited resources to support them. The Challenge trial flips that paradigm: recovery isn't passive. Exercise is not a 'nice to have' — it is a powerful, life-prolonging intervention. Second, access to structured exercise programs are not currently a standard-of-care for cancer survivors in Canada. That must change. These programs require relatively modest investment compared to the high costs of systemic therapies — yet they deliver survival benefits on par with expensive drugs. And unlike drugs, exercise can also reduce cardiovascular risk, improve mental health, and enhance overall quality of life. Third, this is a Canadian success story. The Challenge trial was conceived, led, and executed by Canadian investigators. The Canadian Cancer Society, together with global partners, funded this 15-year effort — a testament to the power of sustained investment in publicly funded clinical research. At a time when Canada's health research ecosystem faces financial strain, the success of Challenge highlights what's possible when we back bold ideas with the resources they deserve. Finally, the findings call on all of us — policymakers, cancer agencies and clinicians — to act. We must embed exercise into survivorship care across the country and simply telling people to exercise is not enough. This will require funding to support exercise professionals in cancer centres and the community, build incentives for survivor-focused programming, and eliminate structural barriers to participation. Survivorship care is not optional — it's essential. Of course, exercise is not a cure-all. Some patients may be unable to participate due to comorbidities or limitations. But for the majority, supervised aerobic activity like walking or cycling can and should be part of the care plan. Importantly, the Challenge program was designed to be adaptable and accessible — guided by behavioural science, delivered by trained consultants, and tailored to each patient's fitness level. We should applaud the Challenge investigators, the Canadian Cancer Trials Group, and the hundreds of patients who participated in this transformative trial. Their commitment will change how we support people after cancer — not just in Canada, but around the world. Now, it's our turn to rise to the challenge. Dr. Sharlene Gill is a medical oncologist at B.C. Cancer, professor of medicine at the University of B.C., and chair of the GI Disease Site for the Canadian Cancer Trials Group.
